OBJECTIVE: We used ultra-high field MRI to visualize cortical lesion types described by neuropathology in 16 patients with multiple sclerosis (MS) compared with 8 age-matched controls; to characterize the contrast properties of cortical lesions including T2*, T2, T1, and phase images; and to investigate the relationship between cortical lesion types and clinical data. METHODS: We collected, on a 7-T scanner, 2-dimensional fast low-angle shot (FLASH)-T2*-weighted spoiled gradient-echo, T2-weighted turbo spin-echo (TSE) images (0.33 x 033 x 1 mm(3)), and a 3-dimensional magnetization-prepared rapid gradient echo. RESULTS: Overall, 199 cortical lesions were detected in patients on both FLASH-T2* and T2-TSE scans. Seven-tesla MRI allowed for characterization of cortical plaques into type I (leukocortical), type II (intracortical), and type III/IV (subpial extending partly or completely through the cortical width) lesions as described histopathologically. Types III and IV were the most frequent type of cortical plaques (50.2%), followed by type I (36.2%) and type II (13.6%) lesions. Each lesion type was more frequent in secondary progressive than in relapsing-remitting MS. This difference, however, was significant only for type III/IV lesions. T2*-weighted images showed the highest, while phase images showed the lowest, contrast-to-noise ratio for all cortical lesion types. In patients, the number of type III/IV lesions was associated with greater disability (p < 0.02 by Spearman test) and older age (p < 0.04 by Spearman test). CONCLUSIONS: Seven-tesla MRI detected different histologic cortical lesion types in our small multiple sclerosis (MS) sample, suggesting, if validated in a larger population, that it may prove a valuable tool to assess the contribution of cortical MS pathology to clinical disability.
OBJECTIVE: We used ultra-high field MRI to visualize cortical lesion types described by neuropathology in 16 patients with multiple sclerosis (MS) compared with 8 age-matched controls; to characterize the contrast properties of cortical lesions including T2*, T2, T1, and phase images; and to investigate the relationship between cortical lesion types and clinical data. METHODS: We collected, on a 7-T scanner, 2-dimensional fast low-angle shot (FLASH)-T2*-weighted spoiled gradient-echo, T2-weighted turbo spin-echo (TSE) images (0.33 x 033 x 1 mm(3)), and a 3-dimensional magnetization-prepared rapid gradient echo. RESULTS: Overall, 199 cortical lesions were detected in patients on both FLASH-T2* and T2-TSE scans. Seven-tesla MRI allowed for characterization of cortical plaques into type I (leukocortical), type II (intracortical), and type III/IV (subpial extending partly or completely through the cortical width) lesions as described histopathologically. Types III and IV were the most frequent type of cortical plaques (50.2%), followed by type I (36.2%) and type II (13.6%) lesions. Each lesion type was more frequent in secondary progressive than in relapsing-remitting MS. This difference, however, was significant only for type III/IV lesions. T2*-weighted images showed the highest, while phase images showed the lowest, contrast-to-noise ratio for all cortical lesion types. In patients, the number of type III/IV lesions was associated with greater disability (p < 0.02 by Spearman test) and older age (p < 0.04 by Spearman test). CONCLUSIONS: Seven-tesla MRI detected different histologic cortical lesion types in our small multiple sclerosis (MS) sample, suggesting, if validated in a larger population, that it may prove a valuable tool to assess the contribution of cortical MS pathology to clinical disability.
Authors: J T Vaughan; M Garwood; C M Collins; W Liu; L DelaBarre; G Adriany; P Andersen; H Merkle; R Goebel; M B Smith; K Ugurbil Journal: Magn Reson Med Date: 2001-07 Impact factor: 4.668
Authors: Kathryn E Hammond; Meredith Metcalf; Lucas Carvajal; Darin T Okuda; Radhika Srinivasan; Dan Vigneron; Sarah J Nelson; Daniel Pelletier Journal: Ann Neurol Date: 2008-12 Impact factor: 10.422
Authors: Christopher P Gilmore; Gabriele C DeLuca; Lars Bö; Trudy Owens; James Lowe; Margaret M Esiri; Nikos Evangelou Journal: Brain Pathol Date: 2008-12-19 Impact factor: 6.508
Authors: C Mainero; N De Stefano; G Iannucci; M P Sormani; L Guidi; A Federico; M L Bartolozzi; G Comi; M Filippi Journal: Neurology Date: 2001-05-22 Impact factor: 9.910
Authors: Kathryn E Hammond; Janine M Lupo; Duan Xu; Meredith Metcalf; Douglas A C Kelley; Daniel Pelletier; Susan M Chang; Pratik Mukherjee; Daniel B Vigneron; Sarah J Nelson Journal: Neuroimage Date: 2007-11-07 Impact factor: 6.556
Authors: J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero Journal: Neuroimage Date: 2011-04-13 Impact factor: 6.556
Authors: J Maranzano; M Dadar; D A Rudko; D De Nigris; C Elliott; J S Gati; S A Morrow; R S Menon; D L Collins; D L Arnold; S Narayanan Journal: AJNR Am J Neuroradiol Date: 2019-06-20 Impact factor: 3.825
Authors: Jerry S Cheung; Enfeng Wang; XiaoAn Zhang; Emiri Mandeville; Eng H Lo; A Gregory Sorensen; Phillip Zhe Sun Journal: NMR Biomed Date: 2011-07-14 Impact factor: 4.044
Authors: Stuart D Cook; Suhayl Dhib-Jalbut; Peter Dowling; Luca Durelli; Corey Ford; Gavin Giovannoni; June Halper; Colleen Harris; Joseph Herbert; David Li; John A Lincoln; Robert Lisak; Fred D Lublin; Claudia F Lucchinetti; Wayne Moore; Robert T Naismith; Carlos Oehninger; Jack Simon; Maria Pia Sormani Journal: Int J MS Care Date: 2012
Authors: Iris D Kilsdonk; Alexandra Lopez-Soriano; Joost P A Kuijer; Wolter L de Graaf; Jonas A Castelijns; Chris H Polman; Peter R Luijten; Jeroen J J G Geurts; Frederik Barkhof; Mike P Wattjes Journal: J Neurol Date: 2014-04-29 Impact factor: 4.849